Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hemang Thakor"'
Autor:
Hemang Thakor, Jerry W. Shay, Albert J. Fornace, Ziling Fan, Steve J. Strawn, Shubhankar Suman, Bo-Hyun Moon, Santosh Kumar, Kamal Datta
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 95:131-138
Purpose There are uncertainties associated with the prediction of colorectal cancer (CRC) risk from highly energetic heavy ion (HZE) radiation. We undertook a comprehensive assessment of intestinal and colonic tumorigenesis induced after exposure to
Publikováno v:
Radiation Research. 182:345-349
Low-linear energy transfer (low-LET) γ-ray exposure is a risk factor for colorectal cancer (CRC). Due to their high-LET nature, energetic iron ions found in space are expected to pose greater CRC risks to astronauts undertaking long-duration space m
Selective estrogen receptor modulators such as tamoxifen (TAM) significantly improve breast cancer-specific survival for women with estrogen receptor-positive (ER+) disease. However, resistance to TAM remains a major clinical problem. The resistant p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc16ad067b86963c197c84e3916f7ef
https://europepmc.org/articles/PMC4079056/
https://europepmc.org/articles/PMC4079056/
Transfer of a phosphoryl group from autophosphorylated CheA (P-CheA) to CheY is an important step in the bacterial chemotaxis signal transduction pathway. This reaction involves CheY (i) binding to the P2 domain of P-CheA and then (ii) acquiring the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19efb538a02abc2bd33ec15b2bd70b9
https://europepmc.org/articles/PMC3147499/
https://europepmc.org/articles/PMC3147499/
Autor:
Yuriy Gusev, Yue Wang, Mary M. Heckler, Rebecca B. Riggins, Subha Madhavan, Cara C. Schafer, Ye Tian, Salendra Singh, Hemang Thakor
Publikováno v:
Cancer Research. 73:3570-3570
Selective estrogen receptor modulators (SERMs) such as Tamoxifen (TAM) can significantly improve breast cancer-specific survival for women with ER-positive (ER+) disease. However, resistance to TAM remains a major clinical problem. Estrogen-related r